Drug Contraindications, Identification, Interactions and More

emailEmail this page

printPrint this page

phoneFOR MORE INFORMATION ON OUR PRODUCTS, CONTACT A SALES REPRESENTATIVE at 800.388.8884, press 2.

Required Companion Products:

Recommended Wolters Kluwer Health Products

Drug Indications Database™

Provides an Essential Component of Advanced Clinical Information Systems

HELPS PREVENT INAPPROPRIATE PRESCRIBING
Drug Indications Database™ assists in identifying the drugs available to treat a specific medical condition. In doing so, it also facilitates adherence to federal drug use standards, identifies potential off-label drug uses and drug contraindications associated with inappropriately prescribed medications.

FEATURES

  • Drug acceptance level - differentiates between FDA-approved indications, officially recognized unlabeled uses and other known unlabeled uses
  • Role of therapy - distinguishes between short-term use and maintenance drugs
  • Outcome - specifies the “expected” clinical result subsequent to drug use
  • Treatment rank - identifies a specific drug's rank in managing a particular medical condition, (e.g., first-line, alternate)
When applicable, the database also includes:
  • Microorganism code - identifies the microorganism that causes the medical condition
  • Restricted medical condition - specifies drug indications limited to patients with a unique medical condition
  • Co-treatment set - identifies drugs that must be used in combination
  • Proxy - indicates the likelihood that a patient is taking a drug to manage a particular indication

BENEFITS

FOR HEALTH CARE FACILITIES

  • Allows health care providers to differentiate between labeled and common off-label drug uses
  • Assesses appropriate drug selection
  • Helps reduce or eliminate hospitalizations, physician office visits, drug therapy, lab tests and other costs associated with inappropriate drug selection
  • Optimizes therapeutic outcomes by identifying drugs that must be used in combination with other drugs to manage a condition
  • Supports “proxy” medical condition identification, enabling users to infer medical conditions based on drug therapy when other information is unavailable
  • Click here to download the PDF

FOR HEALTH CARE PROVIDERS

  • Allowshealth care providers to differentiate between labeled and common off-label drug uses
  • Assesses appropriate drug selection
  • Helps reduce or eliminate hospitalizations, physician office visits, drug therapy, lab tests and other costs associated with inappropriate drug selection
  • Optimizes therapeutic outcomes by identifying drugs that must be used in combination with other drugs to manage a condition
  • Supports “proxy” medical condition identification, enabling users to infer medical conditions based on drug therapy when other information is unavailable
  • Click here to download the PDF

FOR PAYERS

  • Allows payers to differentiate between labeled and common off-label drug uses
  • Provides OBRA '87 drug selection confirmation
  • Assesses appropriate drug selection
  • Helps reduce or eliminate hospitalizations, physician office visits, drug therapy, lab tests and other costs associated with inappropriate drug selection
  • Optimizes therapeutic outcomes by identifying drugs that must be used in combination with other drugs to manage a condition
  • Supports “proxy” medical condition identification, enabling users to infer medical conditions based on drug therapy when other information is unavailable
  • Click here to download the PDF

FOR PHARMACISTS

  • Allows pharmacists to differentiate between labeled and common off-label drug uses
  • Provides long-term care pharmacists with OBRA '87 drug selection confirmation
  • Assesses appropriate drug selection
  • Helps reduce or eliminate hospitalizations, physician office visits, drug therapy, lab tests and other costs associated with inappropriate drug selection
  • Optimizes therapeutic outcomes by identifying drugs that must be used in combination with other drugs to manage a condition
  • Supports “proxy” medical condition identification, enabling users to infer medical conditions based on drug therapy when other information is unavailable
  • Click here to download the PDF

This product is produced and delivered to customers on a weekly, monthly or quarterly basis.